tiprankstipranks
Biostar Pharmaceuticals (BSPM)
OTHER OTC:BSPM
US Market

Biostar Pharmaceuticals (BSPM) Stock Price & Analysis

49 Followers

BSPM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.01
Previous Close$0.01
Volume9.43K
Average Volume (3M)N/A
Market Cap
$264.00
Enterprise Value$2.06M
Total Cash (Recent Filing)$364.97K
Total Debt (Recent Filing)$2.43M
Price to Earnings (P/E)N/A
Beta5080.04
May 19, 2017
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding2,637,188
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation1413.64
R-Squared0.02
Alpha229.58
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.49
Enterprise Value/Gross Profit2.25
Enterprise Value/Ebitda0.42
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

BSPM FAQ

What was Biostar Pharmaceuticals’s price range in the past 12 months?
Biostar Pharmaceuticals lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
    What is Biostar Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Biostar Pharmaceuticals’s upcoming earnings report date?
    Biostar Pharmaceuticals’s upcoming earnings report date is May 19, 2017 which is 2505 days ago.
      How were Biostar Pharmaceuticals’s earnings last quarter?
      Biostar Pharmaceuticals released its earnings results on Apr 13, 2017. The company reported -$0.38 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.38.
        Is Biostar Pharmaceuticals overvalued?
        According to Wall Street analysts Biostar Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biostar Pharmaceuticals pay dividends?
          Biostar Pharmaceuticals does not currently pay dividends.
          What is Biostar Pharmaceuticals’s EPS estimate?
          Biostar Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Biostar Pharmaceuticals have?
          Biostar Pharmaceuticals has 2,637,000 shares outstanding.
            What happened to Biostar Pharmaceuticals’s price movement after its last earnings report?
            Biostar Pharmaceuticals reported an EPS of -$0.38 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
              Which hedge fund is a major shareholder of Biostar Pharmaceuticals?
              Currently, no hedge funds are holding shares in BSPM
              ---

              Biostar Pharmaceuticals Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Biostar Pharmaceuticals

              BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cel-Sci
              BioCryst
              Bellerophon
              Cyclacel Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis